Daxor Corporation - DXR- Profile

Daxor Corporation. The Group's principal activities are to operate human sperm and blood bank, to develop and market medical instrument, which measures human blood volume. The medical instrument is known as blood volume analyzer (BVA-100). The instrument is useful in situations like hemorrhage or surgery wherein it is essential to know the blood volume in the human body. The blood banking services include autologous blood banking services, in which donors deposit their own blood up to ten years. This process eliminates donor transmitted diseases as the donors can receive their own blood at any point of emergency. Volumex utilizes Albumin I-131, which is a classic tracer used for blood volume measurement. BVA-100 is marketed either on a direct sale, lease, or an instrument loaner basis to various potential users, including hospitals, surgi-centers, and imaging centers. It also provides special screening for rare hereditary recessive genetic traits. Equipment sales and related accounted for 56% of 2005 revenues; Cryobanking and related 44%